Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors

Journal of Neuroscience Research

Volumn 85, Issue 12, 2007, Pages 2741-2755

  Rangel, Alejandra ^a   Burgaya, Ferran ^a   Gavín, Rosalina ^a   Soriano, Eduardo ^a   Aguzzi, Adriano ^b   Del Río, José A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cellular prion protein; Epileptic seizure; Kainate binding receptors; Neuronal excitotoxicity

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR 6; GLUTAMATE RECEPTOR 7; KAINIC ACID RECEPTOR; PRION PROTEIN;

ANIMAL TISSUE; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; DISEASE SUSCEPTIBILITY; HIPPOCAMPUS; KAINIC ACID; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; ORGAN CULTURE TECHNIQUES; ORGANIC CHEMICALS; PRIONS; RECEPTORS, AMPA; RNA, SMALL INTERFERING; SEIZURES; TRANSFECTION;

EID: 34548331735     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21215     Document Type: Conference Paper

References (71)

1. Aguzzi A, Polymenidou M. 2004. Mammalian prion biology: one century of evolving concepts. Cell 116:313-327.
2. Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. 2001. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 276:39145-39149.
3. Brown DR, Clive C, Haswell SJ. 2001. Antioxidant activity related to copper binding of native prion protein. J Neurochem 76:69-76.
4. Brown DR, Nicholas RS, Canevari L. 2002. Lack of prion protein expression results in a neuronal phenotype sensitive to stress. J Neurosci Res 67:211-224.
5. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H. 1997a. The cellular prion protein binds copper in vivo. Nature 390:684-687.
6. Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA. 1997b. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp Neurol 146:104-112.
7. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
8. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. 1992. Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
9. Burgaya F, Girault JA. 1996. Cloning of focal adhesion kinase, pp125FAK, from rat brain reveals multiple transcripts with different patterns of expression. Brain Res Mol Brain Res 37:63-73.
10. Coitinho AS, Dietrich MO, Hoffmann A, Dall'Igna OP, Souza DO, Martins VR, Brentani RR, Izquierdo I, Lara DR. 2002. Decreased hyperlocomotion induced by MK-801, but not amphetamine and caffeine in mice lacking cellular prion protein (PrP(C)). Brain Res Mol Brain Res 107:190-194.
11. Colling SB, Collinge J, Jefferys JG. 1996. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 209:49-52.
12. Colling SB, Khana M, Collinge J, Jefferys JG. 1997. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 755:28-35.
13. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. 1994. Prion protein is necessary for normal synaptic function. Nature 370:295-297.
14. Che Y, Yu YM, Han PL, Lee JK. 2001. Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure. Brain Res Mol Brain Res 94:157-165.
15. Chen S, Mange A, Dong L, Lehmann S, Schachner M. 2003. Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci 22:227-233.
16. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. 2002. Cellular prion protein transduces neuroprotective signals. EMBO J 21:3317-3326.
17. Daude N, Marella M, Chabry J. 2003. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. J Cell Sci 116:2775-2779.
18. Del Rio JA, Heimlich B, Borrell V, Forster E, Drakew A, Alcantara S, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Derer P, Frotscher M, Soriano E. 1997. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 385:70-74.
19. Ferrer I, Blanco R, Carmona M, Puig B, Dominguez I, Vinals F. 2002. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat. Acta Neuropathol (Berl) 103:391-407.
20. Ford MJ, Burton LJ, Li H, Graham CH, Frobert Y, Grassi J, Hall SM, Morris RJ. 2002. A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience 111:533-551.
21. Fournier JG. 2001. Non neuronal cellular prion protein. Int Rev Cytol 208:121-160.
22. Frandsen A, Drejer J, Schousboe A. 1989. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors. J Neurochem 53:297-299.
23. Gavin R, Braun N, Nicolas O, Parra B, Urena JM, Mingorance A, Soriano E, Torres JM, Aguzzi A, del Rio JA. 2005. PrP(106-126) activates neuronal intracellular kinases and Egr1 synthesis through activation of NADPH-oxidase independendy of PrPc. FEBS Lett 579:4099-4106.
24. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, Dawson VL. 2000. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A 97:436-441.
25. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, Brentani RR. 2000. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 76:85-92.
26. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
27. Irving EA, Bamford M. 2002. Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
28. Jeon SH, Kim YS, Bae CD, Park JB. 2000. Activation of JNK and p38 in rat hippocampus after kainic acid induced seizure. Exp Mol Med 32:227-230.
29. Jiang W, Van Cleemput J, Sheerin AH, Ji SP, Zhang Y, Saucier DM, Corcoran ME, Zhang X. 2005. Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance. J Neurosci Res 81:581-588.
30. Jorgensen MB, Finsen BR, Jensen MB, Castellano B, Diemer NH, Zimmer J. 1993. Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp Neurol 120:70-88.
31. Kretzschmar HA, Prusiner SB, Stowring LE, DeArmond SJ. 1986. Scrapie prion proteins are synthesized in neurons. Am J Pathol 122:1-5.
32. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Yokoyama T, Itohara S, Onodera T. 1999. Prions prevent neuronal cell-line death. Nature 400(6741):225-226.
33. Lee JY, Cole TB, Palmiter RD, Koh JY. 2000. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci 20:RC79.
34. Lerma J. 2006. Kainate receptor physiology. Curr Opin Pharmacol 6:89-97.
35. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
36. Lledo PM, Tremblay P, DeArmond SJ, Prusiner SB, Nicoll RA. 1996. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc Natl Acad Sci U S A 93:2403-2407.
37. Maglio LE, Martins VR, Izquierdo I, Ramirez OA. 2006. Role of cellular prion protein on LTP expression in aged mice. Brain Res 1097:11-18.
38. Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. 2004. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 131:58-64.
39. Mao L, Tang Q, Samdani S, Liu Z, Wang JQ. 2004. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur J Neurosci 19:1207-1216.
40. Martins VR, Linden R, Prado MA, Walz R, Sakamoto AC, Izquierdo I, Brentani RR. 2002. Cellular prion protein: on the road for functions. FEBS Lett 512:25-28.
41. McKhann GM, 2nd, Wenzel HJ, Robbins CA, Sosunov AA, Schwartzkroin PA. 2003. Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 122:551-561.
42. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, Williams A, Bell JE. 2004. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165:227-235.
43. Moleres FJ, Velayos JL. 2005. Expression of PrP(C) in the rat brain and characterization of a subset of cortical neurons. Brain Res 1056:10-21.
44. Monnet C, Gavard J, Mege RM, Sobel A. 2004. Clustering of cellular prion protein induces ERK1/2 and stathmin phosphorylation in GT1-7 neuronal cells. FEBS Lett 576:114-118.
45. Moser M, Colello RJ, Pott U, Oesch B. 1995. Developmental expression of the prion protein gene in glial cells. Neuron 14:509-517.
46. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heinemann SF. 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392:601-605.
47. Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, Montero M, Meyer M, Gramsbergen JB, Zimmer J. 2005. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord 4:435-452.
48. Paarmann I, Frermann D, Keller BU, Hollmann M. 2000. Expression of 15 glutamate receptor subunits and various splice variants in tissue slices and single neurons of brainstem nuclei and potential functional implications. J Neurochem 74:1335-1345.
49. Pei DS, Guan QH, Sun YF, Zhang QX, Xu TL, Zhang GY. 2005. Neuroprotective effects of GluR6 antisense oligodeoxynucleotides on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 region. J Neurosci Res 82:642-649.
50. Peng YG, Clayton EC, Means LW, Ramsdell JS. 1997. Repeated independent exposures to domoic acid do not enhance symptomatic toxicity in outbred or seizure-sensitive inbred mice. Fundam Appl Toxicol 40:63-67.
51. Popovici T, Represa A, Crepel V, Barbin G, Beaudoin M, Ben-Ari Y. 1990. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res 536:183-194.
52. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
53. Prusiner SB. 1998a. The prion diseases. Brain Pathol 8:499-513.
54. Prusiner SB. 1998b. Prions. Proc Natl Acad Sci U S A 95:13363-13383.
55. Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. 1998. Prion protein biology. Cell 93:337-348.
56. Sakudo A, Onodera T, Suganuma Y, Kobayashi T, Saeki K, Ikuta K. 2006. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini Rev Med Chem 6:589-601.
57. Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M. 2005. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169:341-354.
58. Schmued LC, Hopkins KJ. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
59. Sperk G. 1994. Kainic acid seizures in the rat. Prog Neurobiol 42:1-32.
60. Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD. 2006. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci U S A 103:3416-3421.
61. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
62. Telfeian AE, Federoff HJ, Leone P, During MJ, Williamson A. 2000. Overexpression of GluR6 in rat hippocampus produces seizures and spontaneous nonsynaptic bursting in vitro. Neurobiol Dis 7:362-374.
63. Tobler I, Deboer T, Fischer M. 1997. Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 17:1869-1879.
64. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, Manson JC. 1996. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380:639-642.
65. Vassallo N, Herms J. 2003. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 86:538-544.
66. Volmat V, Pouyssegur J. 2001. Spatiotemporal regulation of the p42/p44 MAPK pathway. Biol Cell 93:71-79.
67. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, Brentani RR. 1999. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 40:1679-1682.
68. Walz R, Castro RM, Velasco TR, Carlotti CG Jr, Sakamoto AC, Brentani RR, Martins VR. 2002. Cellular prion protein: implications in seizures and epilepsy. Cell Mol Neurobiol 22:249-257.
69. Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, Zerr I. 2004. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 372:146-150.
70. Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL. 1986. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A 83:7104-7108.
71. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR. 2002. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 21:3307-3316.